A single institution pilot trial of vaccination with an autologoeus TriMix-dendritic cell vaccine combined with sequential interferon alfa-2b or ipilumumab in patients with advanced melanoma

Scriptie/masterproef: Master's Thesis

Uittreksel

No abstract available
Datum Prijs2009
TaalEnglish
BegeleiderBart Neyns (Promotor) & Jacques De Grève (Promotor)

Citeer dit

'